• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三羟甲基丙烷盐酸盐溶解度调节不对称膜片:统计优化与评价。

Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation.

机构信息

Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India.

出版信息

AAPS PharmSciTech. 2012 Mar;13(1):174-83. doi: 10.1208/s12249-011-9738-3. Epub 2011 Dec 20.

DOI:10.1208/s12249-011-9738-3
PMID:22183255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3299447/
Abstract

The aim of the present study was to develop asymmetric membrane (AM) tablets for controlled delivery of highly water-soluble antihistaminic drug triprolidine hydrochloride. The solubility of triprolidine hydrochloride was modulated through the incorporation of coated sodium chloride crystals encapsulated with asymmetric membrane coating polymer, cellulose acetate butyrate. Formulation of AM tablets was based on a 2(3) factorial design to study the effect of formulation variables, namely, polymer concentration, level of pore former, and amount of osmogen on the in vitro release. Core tablets prepared by wet granulation and coated with asymmetric membrane by a dip coating method were evaluated. Statistical analysis was done with the Design Expert Software 8.0.2 (USA), and the polynomial equation generated by Pareto charts was used for validation of the experimental design. The interaction chart and response surface plots deduced the simultaneous effect of independent variables on in vitro drug release. The in vitro drug release was inversely proportional and directly related to the level(s) of polymer and pore former in the membrane, respectively. The level of osmogen not only increased the osmotic pressure but also controlled the drug release due to a common ion effect. The drug release of the optimized formulation (F6) followed zero-order kinetics, which would be capable of reducing the administration, and was stable over 3 months. SEM photographs revealed asymmetry in membrane structure.

摘要

本研究旨在开发不对称膜(AM)片剂,用于控制高水溶性抗组胺药盐酸曲普利啶的释放。通过将包裹有不对称膜包衣聚合物醋酸丁酸纤维素的包衣氯化钠晶体掺入,调节盐酸曲普利啶的溶解度。AM 片剂的配方基于 2(3) 因子设计,以研究配方变量(即聚合物浓度、致孔剂水平和渗透压调节剂的用量)对体外释放的影响。通过湿法制粒制备芯片,并通过浸涂法用不对称膜包衣。使用 Design Expert Software 8.0.2(美国)进行统计分析,并使用 Pareto 图生成的多项式方程对实验设计进行验证。交互图和响应曲面图推导出独立变量对体外药物释放的协同影响。体外药物释放与膜中的聚合物和致孔剂水平呈反比和直接相关。渗透压调节剂的水平不仅增加了渗透压,而且由于同离子效应,还控制了药物释放。优化配方(F6)的药物释放遵循零级动力学,这将能够减少给药次数,并且在 3 个月内保持稳定。SEM 照片显示了膜结构的不对称性。

相似文献

1
Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation.三羟甲基丙烷盐酸盐溶解度调节不对称膜片:统计优化与评价。
AAPS PharmSciTech. 2012 Mar;13(1):174-83. doi: 10.1208/s12249-011-9738-3. Epub 2011 Dec 20.
2
Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system.盐酸苯福林不对称膜囊:一种渗透压控制的药物传递系统。
Curr Drug Deliv. 2011 Sep;8(5):474-82. doi: 10.2174/156720111796642345.
3
Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets.制剂参数对普萘洛尔从不对称膜包衣片中释放特性的影响。
Eur J Pharm Biopharm. 2007 Nov;67(3):725-31. doi: 10.1016/j.ejpb.2007.04.009. Epub 2007 Apr 21.
4
Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.渗透压调节型漂浮不对称膜胶囊用于盐酸雷尼替丁的控制型定位释放:通过中心复合设计进行优化。
AAPS PharmSciTech. 2012 Dec;13(4):1492-501. doi: 10.1208/s12249-012-9870-8. Epub 2012 Oct 27.
5
Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.氟比洛芬基本渗透泵片的处方设计与表征
PDA J Pharm Sci Technol. 2014 Jul-Aug;68(4):333-46. doi: 10.5731/pdajpst.2014.00984.
6
Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.用于结肠特异性给药系统的壳聚糖基控孔渗透泵:制剂变量筛选及体外研究
Int J Pharm. 2007 Mar 6;332(1-2):115-24. doi: 10.1016/j.ijpharm.2006.09.038. Epub 2006 Sep 29.
7
Development of controlled release osmotic pump tablet of glipizide solid dispersion.格列吡嗪固体分散体控释渗透泵片的研制。
Curr Drug Deliv. 2014;11(6):817-27. doi: 10.2174/15672018113109990040.
8
Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.格列吡嗪渗透控释片的处方设计与优化:热熔制粒法
Ther Deliv. 2010 Dec;1(6):763-74. doi: 10.4155/tde.10.71.
9
Statistical optimization and in vitro evaluation of metformin hydrochloride asymmetric membrane capsules prepared by a novel semiautomatic manufacturing approach.采用新型半自动制造方法制备的盐酸二甲双胍不对称膜胶囊的统计优化及体外评价
ISRN Pharm. 2013 Dec 8;2013:719196. doi: 10.1155/2013/719196. eCollection 2013.
10
Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release.不对称膜片药物释放的机制研究:介质梯度(渗透压和浓度)的影响以及潜在包衣失败对体外释放的影响。
Pharm Res. 2007 Feb;24(2):288-97. doi: 10.1007/s11095-006-9142-y. Epub 2006 Dec 19.

引用本文的文献

1
Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.基于质量源于设计(QbD)的数值和图形优化技术,开发渗透泵控释盐酸甲氧氯普胺片。
Drug Des Devel Ther. 2020 Nov 26;14:5217-5234. doi: 10.2147/DDDT.S278918. eCollection 2020.
2
Cellulose Acetate 398-10 Asymmetric Membrane Capsules for Osmotically Regulated Delivery of Acyclovir.用于阿昔洛韦渗透调控递送的醋酸纤维素398 - 10不对称膜胶囊
J Pharm (Cairo). 2016;2016:8471520. doi: 10.1155/2016/8471520. Epub 2016 Feb 11.
3
Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.渗透压调节型漂浮不对称膜胶囊用于盐酸雷尼替丁的控制型定位释放:通过中心复合设计进行优化。
AAPS PharmSciTech. 2012 Dec;13(4):1492-501. doi: 10.1208/s12249-012-9870-8. Epub 2012 Oct 27.

本文引用的文献

1
Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system.盐酸苯福林不对称膜囊:一种渗透压控制的药物传递系统。
Curr Drug Deliv. 2011 Sep;8(5):474-82. doi: 10.2174/156720111796642345.
2
A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation.一种使用非对称膜技术的新型胃滞留渗透泵胶囊:体外和体内评价。
Pharm Res. 2010 Jan;27(1):105-14. doi: 10.1007/s11095-009-9984-1. Epub 2009 Oct 27.
3
Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug.湿法诱导相转变药物递送系统:一种实现难溶性药物渗透、控释和A级体内体外相关性的手段。
Drug Dev Ind Pharm. 2008 Jul;34(7):735-43. doi: 10.1080/03639040801911032.
4
Development of a novel osmotically driven drug delivery system for weakly basic drugs.一种用于弱碱性药物的新型渗透驱动药物递送系统的研发。
Eur J Pharm Biopharm. 2008 Jun;69(2):667-74. doi: 10.1016/j.ejpb.2007.12.017. Epub 2007 Dec 28.
5
Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.膜胶囊中的不对称膜:实现头孢羟氨苄延迟和渗透流动的一种手段。
Eur J Pharm Biopharm. 2008 Jun;69(2):658-66. doi: 10.1016/j.ejpb.2007.12.011. Epub 2007 Dec 23.
6
Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets.制剂参数对普萘洛尔从不对称膜包衣片中释放特性的影响。
Eur J Pharm Biopharm. 2007 Nov;67(3):725-31. doi: 10.1016/j.ejpb.2007.04.009. Epub 2007 Apr 21.
7
Diflunisal salts of bupivacaine, lidocaine and morphine. Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model.布比卡因、利多卡因和吗啡的双氟尼酸酯盐。在体外透析模型中利用同离子效应延长布比卡因从混合盐混悬液中的释放。
Eur J Pharm Sci. 2007 Jul;31(3-4):172-9. doi: 10.1016/j.ejps.2007.03.005. Epub 2007 Mar 19.
8
In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug.用于难溶性药物渗透释放的原位形成不对称膜胶囊。
PDA J Pharm Sci Technol. 2007 Jan-Feb;61(1):24-36.
9
Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility.通过不对称膜的渗透流:一种控制递送不同溶解度药物的方法。
AAPS PharmSciTech. 2006 Jul 7;7(3):56. doi: 10.1208/pt070356.
10
Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.用于盐酸地尔硫卓控释的改性瓜尔胶基质片剂
J Control Release. 2004 Mar 24;95(3):567-77. doi: 10.1016/j.jconrel.2003.12.019.